Program TRANSCAN-2 - badania z zakresu onkologii
- Development and validation of methods to investigate human tumour heterogeneity (including heterogeneity between the primary tumour and the metastatic sites).
- Studies on human tumour heterogeneity in order to guide therapeutic intervention and identify new therapeutic targets.
- Development of new precision therapeutic strategies that may prevent human tumour recurrence or resistance to therapy by counteracting tumour heterogeneity.
Źródło: www.granty-na-badania.com
Tagi: TRANSCAN-2, onkologia, badania
wstecz Podziel się ze znajomymi